Incyte (INCY) AI Analysis

INCY$122.27+1.97 +1.64%
BiotechnologyLarge CapHigh Quality
Compare
Market cap$24.92BEnterprise value$21.80BRevenue (TTM)$6.01BMarket positionTop 25%

Score

51
Neutral
Value
37
Quality
73
Growth
42

AI Score 65. Incyte Corporation has a market cap of $24.47 billion and a high price-to-earnings ratio of 57.16, indicating potential overvaluation. Despite strong gross profit margins of 92.69% and a solid current ratio of 3.84, the company has reported negative net income in recent quarters, which raises concerns about its profitability and growth sustainability

Incyte (INCY) AI Analysis

INCY price $122.27 +1.97 +1.64%

Ticker
INCY
Price
$122.27
Change
+1.97 +1.64%
Market cap
$24.92B
P/E
60.78
Forward P/E
15.73
Dividend yield
0.00%
Beta
0.78
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
51
Value
37
Quality
73
Growth
42

Stocklytics score rationale: value 37, quality 73, growth 42.

AI Score 65. Incyte Corporation has a market cap of $24.47 billion and a high price-to-earnings ratio of 57.16, indicating potential overvaluation. Despite strong gross profit margins of 92.69% and a solid current ratio of 3.84, the company has reported negative net income in recent quarters, which raises concerns about its profitability and growth sustainability

Insights · Forecast · Financials · Learn

Stocklytics home · Screener